QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-revvity-raises-price-target-to-105

Barclays analyst Luke Sergott maintains Revvity (NYSE:RVTY) with a Overweight and raises the price target from $100 to $105.

 baird-maintains-outperform-on-revvity-raises-price-target-to-123

Baird analyst Catherine Ramsey maintains Revvity (NYSE:RVTY) with a Outperform and raises the price target from $122 to $123.

 tech-stocks-rally-gold-tumbles-on-us-china-trade-progress-whats-moving-markets-monday

Wall Street extended its record-setting streak on Monday, with major large-cap indices logging a third consecutive session of s...

 revvity-lifts-profit-outlook-launches-1-billion-buyback-plan

Revvity Inc. (NYSE: RVTY) announced mixed Q3 results, beating EPS but missing revenue estimates, leading to a decline in stock ...

 revvity-raises-fy2025-adj-eps-guidance-from-485-495-to-490-500-vs-486-est-widens-fy2025-sales-guidance-from-2840b-2880b-to-2830b-2880b-vs-2849b-est

Revvity (NYSE:RVTY) raises FY2025 Adj EPS guidance from $4.85-$4.95 to $4.90-$5.00 vs $4.86 analyst estimate. Widens FY2025 sal...

 revvity-q3-adj-eps-118-beats-114-estimate-sales-698949m-miss-700457m-estimate

Revvity (NYSE:RVTY) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $1.14 by 3.78 p...

 earnings-scheduled-for-october-27-2025

Companies Reporting Before The Bell • Keurig Dr Pepper (NASDAQ:KDP) is projected to report quarterly earnings at $0.54 per sha...

 revvity-earnings-preview
Revvity Earnings Preview
10/24/2025 14:02:25

 guggenheim-initiates-coverage-on-revvity-with-neutral-rating

Guggenheim analyst Subbu Nambi initiates coverage on Revvity (NYSE:RVTY) with a Neutral rating.

 evercore-isi-group-maintains-outperform-on-revvity-lowers-price-target-to-106

Evercore ISI Group analyst Vijay Kumar maintains Revvity (NYSE:RVTY) with a Outperform and lowers the price target from $108...

Core News & Articles

Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease scr...

 b-of-a-securities-maintains-buy-on-revvity-lowers-price-target-to-99

B of A Securities analyst Michael Ryskin maintains Revvity (NYSE:RVTY) with a Buy and lowers the price target from $110 to $99.

 alphabet-apple-fuel-tech-rebound-gold-defies-gravity-whats-moving-markets-wednesday

Wall Street staged a tentative rebound on Wednesday after two straight sessions of heavy tech losses, as rallies in Alphabet Inc.

 revvity-unveils-phsense-reagents-to-advance-internalization-studies-in-drug-discovery

Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION